Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Exosome Intranasal Instillation for the Treatment of Parkinson's Disease
Who is this study for? Patients with Parkinson's disease
What treatments are being studied? AlloRx
Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
This trial will study the safety and efficacy of intranasal instillation of cultured allogeneic adult umbilical cord derived mesenchymal stem cell exosomes for the treatment of Parkinson's Disease
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Diagnosis of Parkinson's Disease
• Understanding and willingness to sign a written informed consent document
Locations
Other Locations
Antigua and Barbuda
Medical Surgical Associates Center
RECRUITING
St John's
Time Frame
Start Date: 2024-08-17
Estimated Completion Date: 2027-01
Participants
Target number of participants: 20
Treatments
Experimental: Treatment Group (AlloEx)
Intranasal instillations of 4 CCs of AlloEx, approximately 800 billion exosomes. Treatments on back-to-back days, totaling 2 doses.
Related Therapeutic Areas
Sponsors
Leads: The Foundation for Orthopaedics and Regenerative Medicine